MCMedicalCodingSoftware
J2003

J2003: Injection, lidocaine hydrochloride, 1 mg

HCPCSActiveBETOS O1E

J2003 is a HCPCS Level II code for injection, lidocaine hydrochloride, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits: units per day

The most units of J2003 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
300 units
MAI 3: Date of Service Edit: Clinical · Clinical: CMS Workgroup
outpatient
300 units
MAI 3: Date of Service Edit: Clinical · Clinical: CMS Workgroup

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute, no documentation overrides it. CMS MUE 2026Q4.

The CMS record for J2003

Long descriptor
Injection, lidocaine hydrochloride, 1 mg

The official wording. This is what the code means.

Short descriptor
Inj, lidocaine hcl, 1 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2024

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J2003

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J2003 is not quite right, the correct code is very often within a few positions of it.

  • J1957Injection, levetiracetam, 5 mg
  • J1958Injection, levetiracetam in sodium chloride, 5 mg
  • J1960Injection, levorphanol tartrate, up to 2 mg
  • J1961Injection, lenacapavir (only for use as hiv treatment), 1 mg
  • J1980Injection, hyoscyamine sulfate, up to 0.25 mg
  • J1990Injection, chlordiazepoxide hcl, up to 100 mg
  • J2001Injection, lidocaine hcl for intravenous infusion, 10 mgterminated
  • J2002Injection, lidocaine hcl in 5% dextrose, 1 mg
  • J2004Injection, lidocaine hcl with epinephrine, 1 mg
  • J2010Injection, lincomycin hcl, up to 300 mg
  • J2020Injection, linezolid, 200 mg
  • J2021Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
  • J2060Injection, lorazepam, 2 mg
  • J2062Loxapine for inhalation, 1 mg
  • J2150Injection, mannitol, 25% in 50 mlterminated
  • J2151Injection, mannitol, 250 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026